Search Results - "Hagen, A I"

Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients by Engstrøm, M. J., Opdahl, S., Hagen, A. I., Romundstad, P. R., Akslen, L. A., Haugen, O. A., Vatten, L. J., Bofin, A. M.

“…Molecular subtyping of breast cancer may provide additional prognostic information regarding patient outcome. However, its clinical significance remains to be…”
Get full text

Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial by Ausen, K., Hagen, A. I., Østbyhaug, H. S., Olafsson, S., Kvalsund, B. J., Spigset, O., Pleym, H.

“…Background Topical administration of tranexamic acid (TXA) may be an alternative to intravenous administration to reduce bleeding with a lower risk of systemic…”
Get full text

Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality by Evans, D G, Harkness, E F, Howell, A, Wilson, M, Hurley, E, Holmen, M M, Tharmaratnam, K U, Hagen, A I, Lim, Y, Maxwell, A J, Moller, P

“…The addition of annual MRI screening to mammography has heightened optimism that intensive screening along with improved treatments may substantially improve…”
Get full text

Risk of recurrence following delayed large flap reconstruction after mastectomy for breast cancer by Isern, A. E., Manjer, J., Malina, J., Loman, N., Mårtensson, T., Bofin, A., Hagen, A. I., Tengrup, I., Landberg, G., Ringberg, A.

“…Background: The aim of this retrospective matched cohort study was to evaluate the rate of recurrence among women with delayed large flap breast reconstruction…”
Get full text

Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: A randomised, placebo-controlled study by Geisler, J., Lønning, P.E., Krag, L.E., Løkkevik, E., Risberg, T., Hagen, A.I., Schlichting, E., Lien, E.A., Øfjord, E.S., Eide, G.E., Polli, A., di Salle, E., Paolini, J.

“…Aromatase inhibitors improve relapse-free survival in early breast cancer, but there is concern about possible detrimental effects on bone mineral density…”
Get full text

Surgery for ruptured abdominal aortic aneurysm and early mortality in women. Risk factors and complication profile by Berge, C, Hagen, A I, Myhre, H O, Haug, E S, Dahl, T

“…Repair of ruptured abdominal aortic aneurysm (rAAA) is reported to have a higher mortality in women than in men. The aim was to study whether this difference…”
Get more information

Mammography screening and trust: The case of interval breast cancer by Solbjør, Marit, Skolbekken, John-Arne, Sætnan, Ann Rudinow, Hagen, Anne Irene, Forsmo, Siri

“…Interval cancer is cancer detected between screening rounds among screening participants. In the Norwegian Breast Cancer Screening Programme, 19 per 10,000…”
Get full text

Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer by LØNNING, Per E, GEISLER, Jürgen, POLLI, Anna, MASSIMINI, Giorgio, KRAG, Lars E, ERIKSTEIN, Bjørn, BREMNES, Yngve, HAGEN, Anne I, SCHLICHTING, Ellen, LIEN, Ernst A, ØFJORD, Erik S, PAOLINI, Jolanda

“…To evaluate potential detrimental effects of exemestane on bone and lipid metabolism. Postmenopausal women with early breast cancer were randomly assigned to…”
Get full text

Genetic epidemiology of BRCA mutations – family history detects less than 50% of the mutation carriers by Møller, Pål, Hagen, Anne Irene, Apold, Jaran, Maehle, Lovise, Clark, Neal, Fiane, Bent, Løvslett, Kjell, Hovig, Eivind, Vabø, Anita

“…Abstract Ten BRCA mutations were demonstrated to be frequent in the Norwegian population. We present maps verifying the uneven distribution of prevalences…”
Get full text

Vitamin D deficiency: A threat to bone health in breast cancer patients during adjuvant treatment with aromatase inhibitors by Lonning, P., Geisler, J., Krag, L. E., Løkkevik, E., Risberg, T., Hagen, A. I., Schlichting, E., Eide, G. E., Di Salle, E.

“…Abstract only 554 Background: To evaluate potential detrimental effects of the aromatase inactivator exemestane on bone, 147 postmenopausal women with early…”
Get full text

Changes in bone metabolism after 2 years’ treatment with exemestane (E) in postmenopausal women with early breast cancer (EBC) at low risk: Follow-up (FU) results of a randomized placebo-controlled study by Lonning, P. E., Geisler, J., Krag, L. E., Ottestad, L., Risberg, T., Hagen, A. I., Schlichting, E., Di Salle, E., Polli, A., Paolini, J.

“…Abstract only…”
Get full text

Estrogens and bone metabolism in postmenopausal women with early breast cancer at low risk treated with exemestane: a randomized placebo-controlled study by Geisler, J., Lonning, P. E., Krag, L. E., Ottestad, L., Bremnes, Y., Hagen, A. I., Schlichting, E., Ofjord, E. S., Polli, A., Massimini, G.

“…Abstract only…”
Get full text

Effect of exemestane on bone: A randomized placebo controlled study in postmenopausal women with early breast cancer at low risk by Lonning, P. E., Geisler, J., Krag, L. E., Ottestad, L., Bremnes, Y., Hagen, A. I., Schlichting, E., Polli, A., Paolini, J., Massimini, G.

“…Abstract only…”
Get full text

Effect of exemestane on bone: A randomized placebo controlled study in postmenopausal women with early breast cancer at low risk by Lonning, P. E., Geisler, J., Krag, L. E., Ottestad, L., Bremnes, Y., Hagen, A. I., Schlichting, E., Polli, A., Paolini, J., Massimini, G.

“…Abstract only…”
Get full text

Lipid and coagulation profile in postmenopausal women with early breast cancer at low risk treated with exemestane: A randomized, placebo-controlled study by Krag, L. E., Geisler, J., Lonning, P. E., Ottestad, L., Risberg, T., Hagen, A. I., Lien, E. A., Polli, A., Paolini, J., Massimini, G.

“…Abstract only…”
Get full text

Estrogens and bone metabolism in postmenopausal women with early breast cancer at low risk treated with exemestane: a randomized placebo-controlled study by Geisler, J., Lonning, P. E., Krag, L. E., Ottestad, L., Bremnes, Y., Hagen, A. I., Schlichting, E., Ofjord, E. S., Polli, A., Massimini, G.

“…Abstract only…”
Get full text

Lipid and coagulation profile in postmenopausal women with early breast cancer at low risk treated with exemestane: A randomized, placebo-controlled study by Krag, L. E., Geisler, J., Lonning, P. E., Ottestad, L., Risberg, T., Hagen, A. I., Lien, E. A., Polli, A., Paolini, J., Massimini, G.

“…Abstract only…”
Get full text

Internet-Delivered Psychological Treatment Options for Panic Disorder: A Review on Their Efficacy and Acceptability by Jennifer Apolin&#225, rio-Hagen

Get full text

Development of a High-Resolution Multi-Locus Microsatellite Typing Method for Colletotrichum gloeosporioides by Mehta, Nikita, Hagen, Ferry, Aamir, Sadaf, Singh, Sanjay K, Baghela, Abhishek

“…Colletotrichum gloeosporioides is an economically important fungal pathogen causing substantial yield losses indifferent host plants. To understand the genetic…”
Get full text

Ultrasound and clinical findings in the metacarpophalangeal joint assessment of show jumping horses in training by Yamada, Ana Lucia M, Pinheiro, Marcelo, Marsiglia, Marilia F, Hagen, Stefano Carlo F, Baccarin, Raquel Yvonne A, da Silva, Luis Claudio L.C

“…Background: Physical exercise is known to cause significant joint changes. Thus, monitoring joint behavior of athletic horses is essential in early disorders…”
Get full text